Day One Biopharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DAWN and other ETFs, options, and stocks.About DAWN
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers.
CEOJeremy Bender
CEOJeremy Bender
Employees181
Employees181
HeadquartersBrisbane, California
HeadquartersBrisbane, California
Founded2018
Founded2018
Employees181
Employees181
DAWN Key Statistics
Market cap639.60M
Market cap639.60M
Price-Earnings ratio-9.42
Price-Earnings ratio-9.42
Dividend yield—
Dividend yield—
Average volume1.42M
Average volume1.42M
High today$6.49
High today$6.49
Low today$6.25
Low today$6.25
Open price$6.31
Open price$6.31
Volume977.20K
Volume977.20K
52 Week high$16.76
52 Week high$16.76
52 Week low$6.08
52 Week low$6.08
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%
People also own
Based on the portfolios of people who own DAWN. This list is generated using Robinhood data, and it’s not a recommendation.